Clinically occult breast lesions are found with increasing frequency b
y breast screening, and several methods have been used to locate suspi
cious occult lesions prior to excision. We have developed a new locali
zation technique called ROLL (radioguided occult lesion localization)
in which a small quantity of Tc-99m-labelled colloidal serum albumin i
s injected into the lesion during mammographic or ultrasonic examinati
on. Correct positioning is checked by scintigraphy. A gamma detecting
probe is then used to locate the lesion and guide its surgical removal
. We report on the first 225 patients in whom we have employed this te
chnique: all had non-palpable breast lesions identified by mammography
or ultrasound as clusters of microcalcifications or small opacities.
Pathology revealed 134 cancers, 133 of which were treated by breast-co
nserving surgery. In all but 2 cases (99%), radiolabelling coincided w
ith the lesion site. X-radiography verified that the specimen removed
contained all of the lesion. Removal of clinically occult breast lesio
ns is greatly facilitated by the gamma probe, which locates the skin p
rojection accurately, allowing choice of the most appropriate incision
, and which can be employed continuously during surgery.